Intravenous (IV) therapy is the process of infusion of liquid substances, such as electrolytes, medicines, nutrition, and blood-based products, directly into the vein as a therapeutic treatment. Intravenous therapy is the fastest way of delivering the fluids to different parts of the body. In cases, wherein the patient requires rapid medication, such as heart attack, stroke, and poisoning, IV medication is preferred. Some of the drugs administered intravenously are chemotherapy drugs antibiotics, antifungal drugs, pain medications, immunoglobulin medication, drugs for low blood pressure, and others. IV therapy operates with a rapid speed, ease to monitor, and avoids side effects on gastrointestinal systems. Research Beam Model: Research Beam Product ID: 1672991 5370 USD New
Intravenous (IV) Therapy and Vein Access Market by Product Type
 

Intravenous (IV) Therapy and Vein Access Market by Product Type (Implantable Port [Single Lumen Implantable Port and Double Lumen Implantable Port], Intravenous Catheter [Peripheral Intravenous Catheter, Central Intravenous Catheter, and Peripherally Inserted Central Catheter], Hypodermic Needles, Infusion Pumps, and Other Products), Medical Application (Volume Expanders, Medication Administration, Blood-based Products, and Nutrition & Buffer Solution), and End User (Hospitals, Ambulatory Surgical Centers, and Clinics) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Intravenous (IV) Therapy and Vein Access Market by Product Type (Implantable Port [Single Lumen Implantable Port and Double Lumen Implantable Port], I

Category : Medical Devices
Published On : June  2017
Pages : 175

request-discount


TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

Intravenous (IV) therapy is the process of infusion of liquid substances, such as electrolytes, medicines, nutrition, and blood-based products, directly into the vein as a therapeutic treatment. Intravenous therapy is the fastest way of delivering the fluids to different parts of the body. In cases, wherein the patient requires rapid medication, such as heart attack, stroke, and poisoning, IV medication is preferred. Some of the drugs administered intravenously are chemotherapy drugs antibiotics, antifungal drugs, pain medications, immunoglobulin medication, drugs for low blood pressure, and others. IV therapy operates with a rapid speed, ease to monitor, and avoids side effects on gastrointestinal systems.

Increase in prevalence of diseases, such as cardiac disorders, blood pressure, cancer; and increase in road accidents drive the market growth. In addition, growth in surgical procedures, rise in trauma cases, rapid technological advancements, increase in awareness among the population, and surge in geriatric population fuel the market further. However, high risk of allergic reaction is expected to restrain the growth of the market during the forecast period. The global intravenous therapy and vein access market has accounted for $18,000 million in 2016, and is estimated to reach $27,971 million by 2023, growing at a CAGR of 6.4% during the forecast period.

The market is segmented on the basis of product type, medical application, end user, and geography. By product type, it is categorized into implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and other products. Medical applications covered in the study include volume expanders, medication administration, blood-based products, and nutrition & buffer solution. Based on end user, it is classified into hospitals, ambulatory surgical centers, and clinics. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY MARKET BENEFITS FOR STKEHOLDERS

  •  The study provides an in-depth analysis of the global intravenous therapy and vein access market, with current trends and future estimations to elucidate the investment pockets.
  •  Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  •  The report provides a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
  •  Extensive analysis of different segments facilitates to understand various products of the market.
  •  Key players are profiled and their strategies are analyzed thoroughly to predict the competitive outlook of the market.

KEY MARKET SEGMENTS

 By Product

  •  Implantable Ports
    •  Single Lumen Implantable Port
    •  Double Lumen Implantable Port
  •  Intravenous Catheters
    •  Peripheral Intravenous Catheter
    •  Central Intravenous Catheter
    •  Peripherally Inserted Central Catheter
  •  Hypodermic Needles
  •  Infusion Pumps
  •  Other Products

 By Medical Application

  •  Volume Expanders
  •  Medication Administration
  •  Blood-based Products
  •  Nutrition & Buffer Solution

 By End User

  •  Hospitals
  •  Ambulatory Surgical Centers
  •  Clinics

 By Geography

  •  North America
    •  U.S.
    •  Canada
    •  Mexico
  •  Europe
    •  Germany
    •  UK
    •  France
    •  Spain
    •  Italy
    •  Rest of Europe
  •  Asia Pacific
    •  Japan
    •  China
    •  India
    •  Rest of Asia-Pacific
  •  LAMEA
    •  Latin America
    •  Middle East
    •  Africa

 List of players profiled in the report

  •  Becton, Dickinson and Company
  •  B. Braun Melsungen AG
  •  Terumo Medical Corporation
  •  Teleflex Medical Inc.
  •  Medtronic Inc.
  •  Smith & Nephew plc.
  •  AngioDynamics, Inc.
  •  Pfizer Inc.
  •  Insulet Corporation
  •  Fresenius SE & Co. KGaA

 List of other players (These companies are not profiled in the report and same can be done on demand)

  •  iRadimed Corporation
  •  Baxter International Inc.
  •  BioScrip, Inc.
  •  Grifols, S.A.
  •  JW Life Science Co. Ltd.
  •  BRIEF-Sichuan Kelun Pharmaceutical Co. Ltd.
  •  CVS Health Corporation
  •  Vifor Pharma Group

CHAPTER 1 INTRODUCTION

1.1.REPORT DESCRIPTION
1.2.KEY BENEFITS
1.3.KEY MARKET SEGMENT
1.4.RESEARCH METHODOLOGY

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1.KEY FINDINGS OF THE STUDY
2.2.CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1.MARKET DEFINITION AND SCOPE
3.2.KEY FINDINGS

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.PORTERS FIVE FORCES ANALYSIS

3.3.1.Bargaining power of buyers
3.3.2.Bargaining power of suppliers
3.3.3.Threat of substitutes
3.3.4.Threat of new entrants
3.3.5.Competitive rivalry

3.4.TOP PLAYERS POSITIONING, 2016
3.5.MARKET DYNAMICS

3.5.1.Drivers

3.5.1.1.Increase in geriatric population
3.5.1.2.Increase in prevalence of chronic diseases
3.5.1.3.Increase in trauma cases and traffic accidents
3.5.1.4.Wide advantages of IV therapy and vein access devices

3.5.2.Restraint

3.5.2.1.Risk of allergic reaction and requirement of skilled professionals
3.5.2.2.Stringent government regulations

3.5.3.Opportunity

3.5.3.1.Lucrative opportunities from emerging economies

CHAPTER 4 IV THERAPY & VEIN ACCESS DEVICES MARKET, BY TYPE

4.1.OVERVIEW

4.1.1.Market size and forecast

4.2.IMPLANTABLE PORT

4.2.1.Key market trends
4.2.2.Key growth factors and opportunities
4.2.3.Market size and forecast
4.2.4.Single Lumen Implantable Port

4.2.4.1.Market size and forecast

4.2.5.Double Lumen Implantable Port

4.2.5.1.Market size and forecast

4.3.INTRAVENOUS CATHETER

4.3.1.Key market trends
4.3.2.Key growth factors and opportunities
4.3.3.Market size and forecast
4.3.4.Peripheral Intravenous Catheter

4.3.4.1.Market size and forecast

4.3.5.Central Intravenous Catheter

4.3.5.1.Market size and forecast

4.3.6.Peripherally Inserted Central Catheter

4.3.6.1.Market size and forecast

4.4.HYPODERMIC NEEDLES

4.4.1.Key market trends
4.4.2.Key growth factors and opportunities
4.4.3.Market size and forecast

4.5.INFUSION PUMPS

4.5.1.Key market trends
4.5.2.Key growth factors and opportunities
4.5.3.Market size and forecast

4.6.OTHER PRODUCTS

4.6.1.Key market trends
4.6.2.Key growth factors and opportunities
4.6.3.Market size and forecast

CHAPTER 5 IV THERAPY & VEIN ACCESS DEVICES MARKET, BY MEDICAL APPLICATION

5.1.OVERVIEW

5.1.1.Market size and forecast

5.2.VOLUME EXPANDERS

5.2.1.Market size and forecast

5.3.MEDICATION ADMINISTRATION

5.3.1.Market size and forecast

5.4.BLOOD BASED PRODUCTS

5.4.1.Market size and forecast

5.5.NUTRITION AND BUFFER SOLUTION

5.5.1.Market size and forecast

CHAPTER 6 IV THERAPY & VEIN ACCESS DEVICES MARKET, BY END-USER

6.1.OVERVIEW

6.1.1.Market size and forecast

6.2.HOSPITALS

6.2.1.Market size and forecast

6.3.AMBULATORY SURGICAL CENTERS

6.3.1.Market size and forecast

6.4.CLINICS

6.4.1.Market size and forecast

CHAPTER 7 IV THERAPY & VEIN ACCESS DEVICES MARKET, BY GEOGRAPHY

7.1.OVERVIEW

7.1.1.Market size and forecast

7.2.NORTH AMERICA

7.2.1.Key market trends
7.2.2.Key growth factors and opportunities
7.2.3.Market size and forecast
7.2.4.U.S. market size and forecast
7.2.5.Canada market size and forecast
7.2.6.Mexico market size and forecast

7.3.EUROPE

7.3.1.Key market trends
7.3.2.Key growth factors and opportunities
7.3.3.Market size and forecast
7.3.4.Germany market size and forecast
7.3.5.France market size and forecast
7.3.6.UK market size and forecast
7.3.7.Italy market size and forecast
7.3.8.Spain market size and forecast
7.3.9.Rest of Europe market size and forecast

7.4.ASIA-PACIFIC

7.4.1.Key market trends
7.4.2.Key growth factors and opportunities
7.4.3.Market size and forecast
7.4.4.Japan market size and forecast
7.4.5.China market size and forecast
7.4.6.India market size and forecast
7.4.7.Rest of Asia-Pacific market size and forecast

7.5.LAMEA

7.5.1.Key market trends
7.5.2.Key growth factors and opportunities
7.5.3.Market size and forecast
7.5.4.Latin America market size and forecast
7.5.5.Middle East market size and forecast
7.5.6.Africa market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1.BECTON, DICKINSON AND COMPANY

8.1.1 Company Overview
8.1.2 Company Snapshot
8.1.3 Operating Business Segments
8.1.4. Key Strategic Moves & Developments

8.2. B.BRAUN MELSUNGEN AG

8.2.1 Company Overview
8.2.2 Company Snapshot
8.2.3 Operating Business Segments
8.2.4.Key Strategic Moves & Developments

8.3.TERUMO MEDICAL CORPORATION

8.3.1 Company Overview
8.3.2 Company Snapshot
8.3.3 Operating Business Segments
8.3.4.Key Strategic Moves & Developments

8.4.TELEFLEX MEDICAL INC.

8.4.1 Company Overview
8.4.2 Company Snapshot
8.4.3 Operating Business Segments
8.4.4.Key Strategic Moves & Developments

8.5.MEDTRONIC INC.

8.5.1 Company Overview
8.5.2 Company Snapshot
8.5.3 Operating Business Segments
8.5.4. Key Strategic Moves & Developments

8.6.SMITH & NEPHEW PLC.

8.6.1 Company Overview
8.6.2 Company Snapshot
8.6.3 Operating Business Segments
8.6.4.Key Strategic Moves & Developments

8.7.ANGIODYNAMICS, INC.

8.7.1 Company Overview
8.7.2 Company Snapshot
8.7.3 Operating Business Segments
8.7.4.Key Strategic Moves & Developments

8.8.PFIZER INC.

8.8.1 Company Overview
8.8.2 Company Snapshot
8.8.3 Operating Business Segments
8.8.4. Key Strategic Moves & Developments

8.9.INSULET CORPORATION

8.9.1 Company Overview
8.9.2 Company Snapshot
8.9.3 Operating Business Segments
8.9.4. Key Strategic Moves & Developments

8.10.FRESENIUS SE & CO. KGAA

8.10.1 Company Overview
8.10.2 Company Snapshot
8.10.3 Operating Business Segments
8.10.4. Key Strategic Moves & Developments

LIST OF TABLES

TABLE 1.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 2.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR IMPLANTABLE PORT, BY TYPE, 2016-2023 ($MILLION)
TABLE 3.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR IMPLANTABLE PORT, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 4.GLOBAL IMPLANTABLE PORT MARKET FOR SINGLE LUMEN IMPLANTABLE PORT, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 5.GLOBAL IMPLANTABLE PORT MARKET FOR DOUBLE LUMEN IMPLANTABLE PORT, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 6.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR INTRAVENOUS CATHETER, BY TYPE, 2016-2023 ($MILLION)
TABLE 7.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR INTRAVENOUS CATHETER, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 8.GLOBAL INTRAVENOUS CATHETER MARKET FOR PERIPHERAL INTRAVENOUS CATHETER, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 9.GLOBAL INTRAVENOUS CATHETER MARKET FOR CENTRAL INTRAVENOUS CATHETER, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 10.GLOBAL INTRAVENOUS CATHETER MARKET FOR PERIPHERALLY INSERTED CENTRAL CATHETER, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 11.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR HYPODERMIC NEEDLES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 12.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR INFUSION PUMPS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 13.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR OTHER PRODUCTS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 14.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 15.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR VOLUME EXPANDERS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 16.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR MEDICATION ADMINISTRATION, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 17.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR BLOOD BASED PRODUCTS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 18.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR NUTRITION AND BUFFER SOLUTION, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 19.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 20.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR HOSPITALS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 21.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 22.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET FOR CLINICS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 23.GLOBAL IV THERAPY & VEIN ACCESS DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 24.NORTH AMERICA IV THERAPY & VEIN ACCESS DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 25.NORTH AMERICA IV THERAPY & VEIN ACCESS DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 26.NORTH AMERICA IV THERAPY & VEIN ACCESS DEVICES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 27.NORTH AMERICA IV THERAPY & VEIN ACCESS DEVICES MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 28.EUROPE IV THERAPY & VEIN ACCESS DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 29.EUROPE IV THERAPY & VEIN ACCESS DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 30.EUROPE IV THERAPY & VEIN ACCESS DEVICES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 31.EUROPE IV THERAPY & VEIN ACCESS DEVICES MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 32.ASIA-PACIFIC IV THERAPY & VEIN ACCESS DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 33.ASIA-PACIFIC IV THERAPY & VEIN ACCESS DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 34.ASIA-PACIFIC IV THERAPY & VEIN ACCESS DEVICES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 35.ASIA-PACIFIC IV THERAPY & VEIN ACCESS DEVICES MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 36.LAMEA IV THERAPY & VEIN ACCESS DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 37.LAMEA IV THERAPY & VEIN ACCESS DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 38.LAMEA IV THERAPY & VEIN ACCESS DEVICES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 39.LAMEA IV THERAPY & VEIN ACCESS DEVICES MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 40.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 41.B BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 42.TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT
TABLE 43.TELEFLEX MEDICAL INC.: COMPANY SNAPSHOT
TABLE 44.MEDTRONIC INC.: COMPANY SNAPSHOT
TABLE 45.SMITH & NEPHEW PLC.: COMPANY SNAPSHOT
TABLE 46.ANGIODYNAMICS, INC.: COMPANY SNAPSHOT
TABLE 47.PFIZER INC.: COMPANY SNAPSHOT
TABLE 48.INSULET CORPORATION: COMPANY SNAPSHOT
TABLE 49.FRESENIUS SE & CO. KGAA: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 1.MARKET SEGMENTATION
FIGURE 2.TOP INVESTMENT POCKETS
FIGURE 3.TOP WINNING STRATEGIES, 2014-2016 (%)
FIGURE 4.TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5.TOP PLAYER POSITIONING: IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016
FIGURE 1.PERCENTAGE DISTRIBUTION OF POPULATION AGED 65 AND OVER BY REGION: 2015 AN D 2050
FIGURE 2.GLOBAL CHRONIC DIEASES DEATH, 2015 (MILLIIONS)
FIGURE 3.ROAD TRAFFIC ACCIDENTS DEATH RATES OF SOME COUNTRIES
FIGURE 4.GLOBAL IMPLANTABLE PORT MARKET FOR SINGLE LUMEN IMPLANTABLE PORT, 2016-2023 ($MILLION)
FIGURE 5.GLOBAL IMPLANTABLE PORT MARKET FOR DOUBLE LUMEN IMPLANTABLE PORT, 2016-2023 ($MILLION)
FIGURE 6.GLOBAL INTRAVENOUS CATHETER MARKET FOR PERIPHERAL INTRAVENOUS CATHETER, 2016-2023 ($MILLION)
FIGURE 7.GLOBAL INTRAVENOUS CATHETER MARKET FOR CENTRAL INTRAVENOUS CATHETER, 2016-2023 ($MILLION)
FIGURE 8.GLOBAL INTRAVENOUS CATHETER MARKET FOR PERIPHERALLY INSERTED CENTRAL CATHETER, 2016-2023 ($MILLION)
FIGURE 9.U.S. IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 10.CANADA IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 $MILLION)
FIGURE 11.MEXICO IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 12.GERMANY IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 13.FRANCE IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 14.UK IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 15.ITALY IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 16.SPAIN IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 17.REST OF EUROPE IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 18.JAPAN IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 19.CHINA IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 20.INDIA IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 21.REST OF ASIA-PACIFIC IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 22.LATIN AMERICA IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 23.MIDDLE EAST IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 24.AFRICA IV THERAPY & VEIN ACCESS DEVICES MARKET, 2016-2023 ($MILLION)

Enquiry Before Buy